Oasis500 invests in Pi Pharma Intelligence
InvestmentsPi Pharma Intelligence joined the Oasis500 portfolio of companies Pi Pharma Intelligence has received a seed investment from Oasis500. This investment will be utilized to enable the commercial launch of the company in the region and finalizing the company HR structure needed for the short term objectives. Pi Pharma Intelligence is grateful for the trust of Oasis500 on its vision and assets.
Shaping the Future of Pharma: Eng. Nusaibah Al-Jaloudi Speaking at GCC Regulatory Affairs Summit
Jan, 2025
Eng. Nusaibah Al-Jaloudi, CEO of PI Pharma Intelligence, will speak at the 10th GCC Regulatory Affairs Pharma Summit, sharing her expertise in healthcare, pharmaceuticals, and innovation.
Pi Pharma Intelligence team attend to workshop arranged by Oasis500
Sep, 2022
Pi Pharma Intelligence team attend to workshop arranged by Oasis500
Countdown to #CPHI2024: Excited to Connect, Collaborate, and Innovate in Milan!
Aug, 2024
With #CPHI2024 in Milan fast approaches, we’re excited to connect with innovative companies and reinforce our strategic partnerships in the pharmaceutical industry.